Blood-based biomarkers may be used to diagnose Alzheimer’s disease, thanks to a worldwide collaborative that includes the Cleveland Clinic, the Clinic recently announced. The Davos Alzheimer’s ...

A $1 million global competition that aims to accelerate Alzheimer's disease research using AI launched today with support ...

It promises the benefits of a 10,000-step walk in just 30 minutes. No gym membership required. Just a pair of shoes and a ...

More than 82 million people could be living with dementia by 2030,1 the majority in low-income and middle-income countries ...

Blood biomarkers might signal Alzheimer’s risk long before symptoms emerge, offering a possible tool for early prevention. A ...

Diseases that affect the brain, like Alzheimer’s and dementia, can start changing the brain long before a person feels sick. This makes them hard to catch early. But finding these diseases early ...

As you age, maintaining a daily habit of walking can prevent cognitive decline, especially for those most at risk, a new ...

Now, researchers in Japan have developed a groundbreaking drug that could prevent further cell death. What is the drug that could help stroke patients? Led by Osaka Metropolitan University Associate ...

Jaya Biosciences Receives Patent Notices of Allowance in Japan, China, and Singapore for Novel Methods of Treating Neurological Diseases, including Alzheimer’s, Further Strengthening its Global ...

With promising drugs in the pipeline, we are on the cusp of "turning the tide" against Alzheimer's. But President Trump's plan to slash research spending could delay or halt progress for years ...

A research team from the University of Kansas Medical Center recently published findings from the CABA (Creatine to Augment Bioenergetics in Alzheimer's) trial, a study that tested whether ...